ELEV - Elevation Oncology, Inc. Stock Price, Fair Value and News
3.60USD-0.13 (-3.49%)Market Closed
Which funds bought or sold ELEV recently?
Which funds are the top buyers of ELEV?
| Fund Name | # Shares | $ Value | % Port. |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 3,886,660 | 19,938,600 | 0.09% |
| Point72 Asset Management, L.P. | 3,368,200 | 17,278,900 | 0.04% |
| TANG CAPITAL MANAGEMENT LLC | 3,060,000 | 15,697,800 | 1.63% |
| Balyasny Asset Management L.P. | 3,055,480 | 15,674,600 | 0.03% |
| Aisling Capital Management LP | 2,834,910 | 14,543,100 | 4.92% |
| venBio Partners LLC | 2,696,130 | 13,831,200 | 4.91% |
| BRAIDWELL LP | 2,377,650 | 12,197,300 | 0.39% |
| Darwin Global Management, Ltd. | 2,332,930 | 11,967,900 | 1.59% |
| BVF INC/IL | 2,312,200 | 11,861,600 | 0.33% |
| CITADEL ADVISORS LLC | 1,569,560 | 8,051,860 | - |
Which funds have put a big percent of portfolio in ELEV?
| Fund Name | $ Value | % Port. |
|---|---|---|
| Aisling Capital Management LP | 14,543,100 | 4.92% |
| venBio Partners LLC | 13,831,200 | 4.91% |
| TANG CAPITAL MANAGEMENT LLC | 15,697,800 | 1.63% |
| Exome Asset Management LLC | 1,894,620 | 1.62% |
| Darwin Global Management, Ltd. | 11,967,900 | 1.59% |
| Velan Capital Investment Management LP | 2,551,140 | 1.16% |
| Affinity Asset Advisors, LLC | 6,509,070 | 0.81% |
| Palo Alto Investors LP | 6,908,400 | 0.78% |
| Logos Global Management LP | 5,130,000 | 0.42% |
| BRAIDWELL LP | 12,197,300 | 0.39% |
Trend of No. of funds that hold ELEV
Changes in Positions
Investor Breakout
Investor Churn (# Increased Holdings)
New Buys
| Fund Name | $ Bought |
|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 19,938,600 |
| Point72 Asset Management, L.P. | 17,278,900 |
| Balyasny Asset Management L.P. | 15,674,600 |
| BRAIDWELL LP | 12,197,300 |
| Darwin Global Management, Ltd. | 11,967,900 |
| Artal Group S.A. | 7,761,770 |
| Palo Alto Investors LP | 6,908,400 |
| Affinity Asset Advisors, LLC | 6,509,070 |
Additions
| Fund Name | % Increased |
|---|---|
| JPMORGAN CHASE & CO | 56,833 |
| Schonfeld Strategic Advisors LLC | 1,151 |
| MORGAN STANLEY | 719 |
| Hudson Bay Capital Management LP | 176 |
| CITADEL ADVISORS LLC | 165 |
| STATE STREET CORP | 162 |
| BlackRock Inc. | 113 |
| BANK OF AMERICA CORP /DE/ | 58.82 |
Reductions
| Fund Name | % Reduced |
|---|---|
| Tower Research Capital LLC (TRC) | -99.85 |
| Ikarian Capital, LLC | -87.36 |
| BOOTHBAY FUND MANAGEMENT, LLC | -84.66 |
| MILLENNIUM MANAGEMENT LLC | -77.64 |
| SPHERA FUNDS MANAGEMENT LTD. | -52.22 |
| ORBIMED ADVISORS LLC | -37.25 |
| TANG CAPITAL MANAGEMENT LLC | -16.57 |
| venBio Partners LLC | -7.48 |
Sold off
| Fund Name | $ Sold |
|---|---|
| Qiming U.S. Ventures Management, LLC | -1,272,770 |
| DAFNA Capital Management LLC | -241,650 |
| RENAISSANCE TECHNOLOGIES LLC | -237,000 |
| TWO SIGMA INVESTMENTS, LP | -195,947 |
| TWO SIGMA ADVISERS, LP | -55,150 |
| Royal Bank of Canada | - |
| Annandale Capital, LLC | -27,000 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | - |